Overview

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

Status:
Terminated
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
Studies of PEG-paclitaxel have been terminated
Phase:
Phase 1
Details
Lead Sponsor:
Enzon Pharmaceuticals, Inc.
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel